JP6364322B2 - Cosmetic or skin preparation - Google Patents
Cosmetic or skin preparation Download PDFInfo
- Publication number
- JP6364322B2 JP6364322B2 JP2014223690A JP2014223690A JP6364322B2 JP 6364322 B2 JP6364322 B2 JP 6364322B2 JP 2014223690 A JP2014223690 A JP 2014223690A JP 2014223690 A JP2014223690 A JP 2014223690A JP 6364322 B2 JP6364322 B2 JP 6364322B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- cosmetic
- oil
- skin external
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 62
- 238000002360 preparation method Methods 0.000 title claims description 40
- 239000003921 oil Substances 0.000 claims description 31
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 28
- 229960000401 tranexamic acid Drugs 0.000 claims description 28
- 150000003904 phospholipids Chemical class 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical class COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 10
- 150000002430 hydrocarbons Chemical class 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 230000007935 neutral effect Effects 0.000 claims description 8
- 239000004215 Carbon black (E152) Substances 0.000 claims description 7
- 239000010696 ester oil Substances 0.000 claims description 7
- 229930195733 hydrocarbon Natural products 0.000 claims description 7
- 150000002314 glycerols Chemical class 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 2
- 229920000223 polyglycerol Polymers 0.000 claims 1
- 235000019198 oils Nutrition 0.000 description 28
- -1 sphingomyelin Chemical compound 0.000 description 25
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 11
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 10
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 9
- 229940032094 squalane Drugs 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 8
- 230000035515 penetration Effects 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000007764 o/w emulsion Substances 0.000 description 7
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 229920001451 polypropylene glycol Polymers 0.000 description 6
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 5
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 4
- 235000010262 sodium metabisulphite Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 3
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 3
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 3
- 229940042880 natural phospholipid Drugs 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229960001679 octinoxate Drugs 0.000 description 3
- 229940049964 oleate Drugs 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 239000004711 α-olefin Substances 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 2
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 2
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 241001072282 Limnanthes Species 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002734 clay mineral Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 239000008344 egg yolk phospholipid Substances 0.000 description 2
- 229940068998 egg yolk phospholipid Drugs 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- CJBFZKZYIPBBTO-UHFFFAOYSA-N isotetradecane Natural products CCCCCCCCCCCC(C)C CJBFZKZYIPBBTO-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 150000008106 phosphatidylserines Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 229940005741 sunflower lecithin Drugs 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 description 1
- IJFVSSZAOYLHEE-SSEXGKCCSA-N 1,2-dilauroyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC IJFVSSZAOYLHEE-SSEXGKCCSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- UUWJHAWPCRFDHZ-UHFFFAOYSA-N 1-dodecoxydodecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC UUWJHAWPCRFDHZ-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-M 4-aminobenzoate Chemical compound NC1=CC=C(C([O-])=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-M 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960003724 dimyristoylphosphatidylcholine Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 239000008350 hydrogenated phosphatidyl choline Substances 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、水中油乳化型の化粧料または皮膚外用剤に関し、さらに詳細には、トラネキサム酸、リゾリン脂質、リン脂質および25℃で液状の特定油剤を含有する、官能特性と経時安定性に優れた水中油乳化型の化粧料または皮膚外用剤に関するものである。 The present invention relates to an oil-in-water emulsified cosmetic or external preparation for skin, and more specifically, contains tranexamic acid, lysophospholipid, phospholipid and a specific oil that is liquid at 25 ° C., and has excellent sensory characteristics and stability over time. Further, the present invention relates to an oil-in-water emulsion type cosmetic or a skin external preparation.
従来、化粧料や皮膚外用剤(以下、化粧料等と記す)に美白効果や抗炎症効果等を付与するためにトラネキサム酸を配合することが行われている。(例えば、特許文献1、特許文献2参照)
しかしながら、トラネキサム酸は結晶性の高い化合物であるため、化粧料等に配合するとトラネキサム酸自体が結晶化し析出したり、また他の成分と結合して析出するなど、化粧料等に安定に配合することが難しい場合があった。特に、水性相を連続相とし、不連続相として油性相が分散した水中油乳化型の化粧料等ではトラネキサム酸により経時的に乳化滴が壊れたり、水性相に粘性を付与する水溶性高分子化合物が凝集して粘性が低下し、クリーミングを起こすなど安定な水中油型の乳化物が得られにくい場合があった。
Conventionally, in order to impart a whitening effect, an anti-inflammatory effect and the like to cosmetics and external preparations for skin (hereinafter referred to as cosmetics), tranexamic acid has been blended. (For example, see Patent Document 1 and Patent Document 2)
However, since tranexamic acid is a highly crystalline compound, when it is formulated in cosmetics, tranexamic acid itself crystallizes and precipitates, or is combined with other components and precipitates stably. Sometimes it was difficult. In particular, in oil-in-water emulsified cosmetics in which the aqueous phase is a continuous phase and the oily phase is dispersed as a discontinuous phase, the water-soluble polymer that breaks emulsified droplets with time due to tranexamic acid or imparts viscosity to the aqueous phase In some cases, it was difficult to obtain a stable oil-in-water emulsion, for example, the compounds aggregated to reduce viscosity and cause creaming.
そこで、高級アルコールと特定の長鎖アシルスルホン酸塩型陰イオン性界面活性剤を組み合わせ、特定のpHに調整することによりトラネキサム酸の結晶析出を抑制した皮膚外用剤が検討されている。(特許文献3参照)
また、モノカプリル酸と多価アルコールのエステル、および非イオン性界面活性剤を組み合わせ、水性成分と油性成分の分離のないクリーム剤等、安定な皮膚外用剤が検討されている。(特許文献4参照)
Therefore, an external preparation for skin that suppresses crystal precipitation of tranexamic acid by combining a higher alcohol and a specific long-chain acylsulfonate type anionic surfactant and adjusting to a specific pH has been studied. (See Patent Document 3)
In addition, stable skin external preparations such as cream agents in which monocaprylic acid and an ester of a polyhydric alcohol and a nonionic surfactant are combined to prevent separation of an aqueous component and an oily component have been studied. (See Patent Document 4)
ところが、特許文献3の方法では化粧料等のpHが酸性域の特定範囲に限定されてしまい、汎用されるpH6を超えた中性域の製品においてはトラネキサム酸の結晶析出の抑制が難しく、製剤化の自由度が狭められてしまうことがある上、肌への適用後にトラネキサム酸に由来する化粧膜の硬さが感じられ、官能上の満足が得られにくい場合があった。
また、特許文献4の方法では化粧料等の安定性は確保できるものの、やはり適用後の肌にトラネキサム酸に由来する化粧膜の硬さが感じられるため、官能上の満足が得られにくい場合があった。
従って、トラネキサム酸を配合しても中性域での十分な安定性と、適用後に硬さの感じられない柔軟な化粧膜を得ることができ、なおかつ肌への浸透感やうるおい感、べたつきのなさなど、適用時および適用後において官能上の満足が得られる化粧料等が望まれていた。
However, in the method of Patent Document 3, the pH of cosmetics and the like is limited to a specific range in the acidic range, and it is difficult to suppress crystal precipitation of tranexamic acid in products in a neutral range exceeding pH 6, which is widely used. In some cases, the degree of freedom of conversion may be narrowed, and the hardness of the cosmetic film derived from tranexamic acid may be felt after application to the skin, making it difficult to achieve sensory satisfaction.
Moreover, although the stability of cosmetics etc. can be ensured by the method of Patent Document 4, since the hardness of the cosmetic film derived from tranexamic acid is still felt on the skin after application, it may be difficult to obtain sensory satisfaction. there were.
Therefore, even if tranexamic acid is added, it is possible to obtain sufficient stability in the neutral range and a flexible cosmetic film that does not feel firm after application, and also has a feeling of penetration into the skin, moisture, and stickiness. There has been a demand for cosmetics that can satisfy sensory satisfaction during and after application.
本発明の課題は、上記問題を解決し、トラネキサム酸を含有してもpH域にとらわれず、特にpH6を超える中性域においても十分な安定性を有しながら、適用後に硬さの感じられない良好な化粧膜を得ることができ、なおかつ肌への適用時および適用後に官能上の満足が得られる水中油乳化型の化粧料または皮膚外用剤を提供することにある。 The object of the present invention is to solve the above-mentioned problems, and even if tranexamic acid is contained, it is not limited to the pH range, and particularly has a sufficient stability even in a neutral range exceeding pH 6, and feels hardness after application. It is an object of the present invention to provide an oil-in-water emulsified cosmetic or external preparation for skin that can provide a satisfactory cosmetic film, and can satisfy sensory satisfaction during and after application to the skin.
本発明者らは上記課題に対し鋭意検討を行った結果、トラネキサム酸を、リゾリン脂質、リン脂質および特定液状油剤の4成分を組み合わせ、乳化して得た水中油型の乳化物が上記課題を解決することを見出し、この知見に基づいて本発明を完成するに至った。 As a result of intensive studies on the above problems, the inventors of the present invention have obtained an oil-in-water emulsion obtained by emulsifying tranexamic acid by combining four components of lysophospholipid, phospholipid and a specific liquid oil. Based on this finding, the present invention has been completed.
すなわち、本発明は、次の成分(A)〜(D)、
(A)トラネキサム酸、(B)リゾリン脂質、(C)リン脂質、(D)炭化水素油およびエステル油からなる群から選ばれる25℃で液状の油剤
を含有し、
前記成分(B)と前記成分(C)の含有質量比(B)/(C)が1/100〜10/1である
ことを特徴とする、水中油乳化型の化粧料または皮膚外用剤である。
また、本発明は、成分(B)と成分(C)の含有質量比(B)/(C)が1/10〜5/1である。
That is, the present invention includes the following components (A) to (D),
(A) tranexamic acid, (B) lysophospholipid, (C) phospholipid, (D) containing a liquid oil at 25 ° C selected from the group consisting of hydrocarbon oil and ester oil ,
The oil- in- water emulsified cosmetic , wherein the content ratio (B) / (C) of the component (B) and the component (C) is 1/100 to 10/1. It is a skin external preparation.
Moreover, as for this invention, the content mass ratio (B) / (C) of a component (B) and a component (C) is 1/10-5/1.
また、本発明は、さらに成分(E)25℃でペースト状の油剤を含有する前記の化粧料または皮膚外用剤である。 Moreover, this invention is said cosmetics or the skin external preparation which contains a paste-form oil agent further at a component (E) 25 degreeC.
また、本発明は、さらに成分(F)グリセリンのポリオキシアルキレン誘導体、ポリグリセリンのポリオキシアルキレン誘導体またはメチルグルコシドのポリオキシアルキレン誘導体から選ばれる1種または2種以上を含有する前記の化粧料または皮膚外用剤である。 In addition, the present invention provides the cosmetic or cosmetic composition further comprising one or more selected from component (F) a polyoxyalkylene derivative of glycerin, a polyoxyalkylene derivative of polyglycerin, or a polyoxyalkylene derivative of methyl glucoside. It is a skin external preparation.
また、本発明は系のpHが6を超える中性域にあることを特徴とする前記の化粧料または皮膚外用剤である。 The present invention also provides the cosmetic or skin external preparation described above, wherein the pH of the system is in a neutral range exceeding 6.
また、本発明は成分(D)の分子量が200〜1000の範囲内にある前記の化粧料または皮膚外用剤である。 Moreover, this invention is said cosmetics or skin external preparation whose molecular weight of a component (D) exists in the range of 200-1000.
また、本発明は25℃における粘度が、20,000mPa・sを超えないことを特徴とする前記の化粧料または皮膚外用剤である。 Moreover, this invention is the said cosmetics or skin external preparation characterized by the viscosity in 25 degreeC not exceeding 20,000 mPa * s.
さらに、本発明は、乳化型の化粧料または皮膚外用剤の乳化滴の最大粒子径が1μmを超えないことを特徴とする前記の化粧料または皮膚外用剤である。 Furthermore, the present invention is the cosmetic or external skin preparation described above, wherein the maximum particle size of the emulsified droplets of the emulsified cosmetic preparation or external skin preparation does not exceed 1 μm.
本発明の化粧料または皮膚外用剤は、水中油乳化型の系にトラネキサム酸を含有しても、pH6を超える中性域においても十分な安定性を有し、なおかつ、適用後の肌にトラネキサム酸由来の硬さが感じられない柔軟な化粧膜を得ることができる。また、適用時に肌への浸透感を有し、適用後の肌もべたつきがなく、うるおい感のある良好な感触を有するものであり、水中油乳化型の化粧料または皮膚外用剤として極めて優れた品質を有する。 The cosmetic or external preparation for skin of the present invention contains tranexamic acid in an oil-in-water emulsion type system, and has sufficient stability in a neutral range exceeding pH 6, and further, tranexam is applied to the skin after application. A flexible decorative film that does not feel the hardness derived from an acid can be obtained. In addition, it has a penetrating feeling on the skin at the time of application, the skin after application is not sticky, has a good feeling of moisture, and is extremely excellent as an oil-in-water emulsion type cosmetic or skin external preparation. Have quality.
以下、本発明を詳細に説明する。
本発明に用いる成分(A)のトラネキサム酸は、化学名:トランス−4−(アミノメチル)シクロヘキサン−1−カルボン酸、で示されるアミノ酸の一種であり、前述のように皮膚に対し美白効果や抗炎症効果を有する成分として知られているほか、止血剤としても用いられることがある。
Hereinafter, the present invention will be described in detail.
The component (A) tranexamic acid used in the present invention is a kind of amino acid represented by the chemical name: trans-4- (aminomethyl) cyclohexane-1-carboxylic acid. In addition to being known as a component having an anti-inflammatory effect, it may also be used as a hemostatic agent.
本発明の化粧料または皮膚外用剤において、成分(A)トラネキサム酸の含有量は特に限定されないが、トラネキサム酸の有効性および製剤の安定性の観点から0.1質量%〜5質量%が好ましく、1質量%〜2質量%がより好ましい。 In the cosmetic or skin external preparation of the present invention, the content of component (A) tranexamic acid is not particularly limited, but is preferably 0.1% by mass to 5% by mass from the viewpoint of the effectiveness of tranexamic acid and the stability of the preparation. 1 mass%-2 mass% are more preferable.
本発明に用いる成分(B)のリゾリン脂質は、2つのアシル基を有するリン脂質に対し、アシル基が1つである改質型リン脂質である。リゾリン脂質は、例えば、ホスフォリパーゼにより2位のエステル結合を加水分解すること(以後、リゾ化と記す)により得ることができる。リゾリン脂質の原材料となるリン脂質としては、例えば、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトール、リゾホスファチジルコリン、スフィンゴミエリン、卵黄レシチン、大豆レシチン、ヒマワリレシチンなどの天然リン脂質、ジラウロイルホスファチジルコリン、ジミリストイルホスファチジルコリン、ジパルミトイルホスファチジルコリン、ジステアロイルホスファチジルコリン、ジオレオイルホスファチジルコリン、パルミトイル・オレオイルホスファチジルコリンなどの合成リン脂質、水素添加卵黄レシチン、水素添加大豆レシチン、水素添加ヒマワリレシチン、水素添加ホスファチジルコリン、水素添加ホスファチジルセリンなどの水素添加リン脂質などを挙げることができる。これらのリン脂質を加水分解することで、各種リゾリン脂質が得られる。リゾリン脂質は疎水基である脂肪酸由来のアシル基が1本しかないため、リン脂質よりも高いHLBを示し、親水性も高いなど、リン脂質とは異なる化学的性質を有する。 The lysophospholipid of component (B) used in the present invention is a modified phospholipid having one acyl group with respect to a phospholipid having two acyl groups. The lysophospholipid can be obtained, for example, by hydrolyzing the ester bond at the 2-position with phospholipase (hereinafter referred to as lysation). Examples of phospholipids used as raw materials for lysophospholipids include natural phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, egg yolk lecithin, soybean lecithin, sunflower lecithin, dilauroyl phosphatidylcholine, Synthetic phospholipids such as myristoyl phosphatidylcholine, dipalmitoyl phosphatidylcholine, distearoyl phosphatidylcholine, dioleoylphosphatidylcholine, palmitoyl oleoylphosphatidylcholine, hydrogenated egg yolk lecithin, hydrogenated soybean lecithin, hydrogenated sunflower lecithin, hydrogenated phosphatidylserine Such as hydrogenated phospholipids It is possible. Various lysophospholipids can be obtained by hydrolyzing these phospholipids. Since lysophospholipid has only one acyl group derived from a fatty acid, which is a hydrophobic group, it has a chemical property different from that of phospholipid, such as a higher HLB and higher hydrophilicity than phospholipid.
また、リゾリン脂質はその構造中に不飽和脂肪酸由来の炭化水素鎖が含まれる場合があるが、この炭化水素鎖の不飽和部分が光や酸素によって酸化され、着色、異臭発生等を引き起こし、品質を低下させる場合がある。そこでこのような品質低下を抑制するために、不飽和部分に水素添加して飽和炭化水素とした水素添加リゾリン脂質がある。本発明において成分(B)のリゾリン脂質は、不飽和脂肪酸が結合したリゾリン脂質も、水素添加リゾリン脂質も含むものであるが、経時的な着色や臭いの変化などを抑制する点から、水素添加大豆リゾリン脂質や水素添加卵黄リゾリン脂質等の水素添加リゾリン脂質がより好ましく、特に水素添加大豆リゾリン脂質が好ましい。 In addition, lysophospholipids may contain hydrocarbon chains derived from unsaturated fatty acids in their structure, but the unsaturated part of these hydrocarbon chains is oxidized by light and oxygen, causing coloration, off-flavor generation, etc. May be reduced. Therefore, in order to suppress such quality deterioration, there is a hydrogenated lysophospholipid that is hydrogenated to an unsaturated portion to be a saturated hydrocarbon. In the present invention, the lysophospholipid of component (B) includes both lysophospholipids to which unsaturated fatty acids are bound and hydrogenated lysophospholipids. From the viewpoint of suppressing coloration and odor changes over time, hydrogenated soybean lysolin. Hydrogenated lysophospholipids such as lipids and hydrogenated egg yolk lysophospholipids are more preferred, and hydrogenated soybean lysophospholipids are particularly preferred.
さらに、本発明において、成分(B)のリゾリン脂質は、リゾホスファチジルコリン、リゾホスファチジルエタノールアミン等の複数種のリゾリン脂質を含有してもよく、特に、リゾホスファチジルコリンを必須に含有することが好ましい。この場合、リゾホスファチジルコリンの含有量は成分(B)中に15質量%以上であることが乳化安定性の点から好ましく、20質量%〜含有することがより好ましい。このようなものは特に水素添加大豆リゾリン脂質等において好適に得ることができる。 Furthermore, in the present invention, the lysophospholipid of component (B) may contain a plurality of types of lysophospholipids such as lysophosphatidylcholine and lysophosphatidylethanolamine, and particularly preferably contains lysophosphatidylcholine essentially. In this case, the content of lysophosphatidylcholine is preferably 15% by mass or more in the component (B) from the viewpoint of emulsion stability, and more preferably 20% by mass to more. Such a thing can be suitably obtained especially in hydrogenated soybean lysophospholipid.
本発明において成分(B)のリゾリン脂質は1種を単独で、または2種以上を組み合わせて用いてもよく、その含有量は特に限定されないが、良好な乳化物を得る上で、好ましくは化粧料等の全量に対して0.01質量%〜10質量%であり、より好ましくは、0.05質量%〜5質量%、特に好ましくは0.1質量%〜1質量%である。 In the present invention, the lysophospholipid of component (B) may be used singly or in combination of two or more, and the content is not particularly limited, but is preferably cosmetic for obtaining a good emulsion. 0.01 mass% to 10 mass%, more preferably 0.05 mass% to 5 mass%, and particularly preferably 0.1 mass% to 1 mass% with respect to the total amount of the material.
本発明に用いる成分(C)のリン脂質としては、リン酸エステル部位をもつ脂質であれば特に限定されず、天然リン脂質でも合成リン脂質であってもよく、またこれらのリン脂質を水素添加した水素添加リン脂質であってもよい。天然リン脂質としては、例えば、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトール、リゾホスファチジルコリン、スフィンゴミエリン、卵黄リン脂質、大豆リン脂質等を挙げることができ、合成リン脂質としては、例えば、ジラウロイルホスファチジルコリン、ジミリストイルホスファチジルコリン、ジパルミトイルホスファチジルコリン、ジステアロイルホスファチジルコリン、ジオレオイルホスファチジルコリン、パルミトイル・オレオイルホスファチジルコリン等を挙げることができる。また、水素添加リン脂質としては、例えば、水素添加大豆リン脂質、水素添加卵黄リン脂質、水素添加ホスファチジルコリン、水素添加ホスファチジルセリン等を挙げることができるが、とりわけ水素添加大豆リン脂質が好適なものとして挙げられる。成分(C)のリン脂質は、1種を単独で用いてもよく、また2種以上を組み合わせ、混合して用いてもよい。 The phospholipid of component (C) used in the present invention is not particularly limited as long as it has a phosphate ester moiety, and may be a natural phospholipid or a synthetic phospholipid, and these phospholipids are hydrogenated. Hydrogenated phospholipids may also be used. Examples of natural phospholipids include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, egg yolk phospholipid, soybean phospholipid, and synthetic phospholipids such as dilauroyl Examples thereof include phosphatidylcholine, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine, distearoylphosphatidylcholine, dioleoylphosphatidylcholine, palmitoyl-oleoylphosphatidylcholine and the like. Examples of the hydrogenated phospholipid include hydrogenated soybean phospholipid, hydrogenated egg yolk phospholipid, hydrogenated phosphatidylcholine, hydrogenated phosphatidylserine, and the like. Can be mentioned. The phospholipid of component (C) may be used alone or in combination of two or more.
本発明において成分(C)の含有量は特に限定されないが、前述の成分(B)との組み合わせにおいて、40℃〜50℃の高温における乳化安定性をより良好にする上で、好ましくは化粧料等の全量に対して0.01質量%〜10質量%であり、より好ましくは、0.1質量%〜5質量%、特に好ましくは0.3質量%〜2質量%である。 In the present invention, the content of the component (C) is not particularly limited, but in the combination with the component (B) described above, it is preferable to improve the emulsion stability at a high temperature of 40 ° C. to 50 ° C. It is 0.01 mass%-10 mass% with respect to whole quantity, etc., More preferably, it is 0.1 mass%-5 mass%, Most preferably, it is 0.3 mass%-2 mass%.
本発明において、成分(B)と成分(C)の含有質量比(B)/(C)は好ましくは1/100〜10/1の範囲内であり、より好ましくは1/10〜5/1、特に好ましくは1/3〜2/1の範囲内である。1/100〜10/1の範囲内であれば乳化安定性、特に40℃〜50℃の高温における乳化安定性が良好であり、さらに25℃で20,000mPa・sを超えないような低粘度の化粧料等、とりわけ化粧水などのような水に近いような低粘度の液状化粧料や、ビタミンC誘導体塩など電解質を含有する乳化型化粧料のような場合においても、良好な経時安定性を示す。より好ましい範囲内であればより良好な経時安定性を示し、特に好ましい範囲内であればさらに良好な経時安定性を示すことはいうまでもない。 In the present invention, the content mass ratio (B) / (C) of the component (B) and the component (C) is preferably in the range of 1/100 to 10/1, more preferably 1/10 to 5/1. Particularly preferably, it is in the range of 1/3 to 2/1. Emulsification stability within the range of 1/100 to 10/1, especially emulsification stability at a high temperature of 40 ° C. to 50 ° C., and a low viscosity that does not exceed 20,000 mPa · s at 25 ° C. Even in the case of liquid cosmetics having a low viscosity such as lotion, especially emulsified cosmetics containing electrolytes such as vitamin C derivative salts, etc. Indicates. Needless to say, better stability over time is shown if it is in a more preferable range, and even better stability is shown if it is in a particularly preferable range.
なお、前述のように、リゾリン脂質はリン脂質のリゾ化により得られるが、本発明において成分(B)のリゾリン脂質は、リゾ化されたものを示す。従って、リゾ化率(全リン脂質類中のリゾリン脂質の比率)が100%でないリン脂質・リゾリン脂質混合物を原料とする場合には、その内のリゾ化されていないリン脂質は本発明の成分(C)に該当する。 As described above, lysophospholipids are obtained by lysolysis of phospholipids. In the present invention, the lysophospholipid of component (B) indicates a lysozyme. Accordingly, when a phospholipid / lysophospholipid mixture whose lysolysis rate (ratio of lysophospholipids in the total phospholipids) is not 100% is used as a raw material, the unlyzed phospholipid is a component of the present invention. Corresponds to (C).
本発明に用いる成分(D)の炭化水素油およびエステル油からなる群から選ばれる25℃で液状の油剤は、特に限定されず、化粧品や皮膚外用剤に使用可能な25℃で液状の炭化水素油またはエステル油であれば何れのものも使用可能である。成分(D)は動物油、植物油、合成油等の起源は問わず、炭化水素油としては、例えば流動パラフィン、重質流動イソパラフィン(水添ポリイソブテン)、軽質流動イソパラフィン、ドデカン、イソドデカン、テトラデカン、イソテトラデカン、ヘキサデカン、イソヘキサデカン、スクワラン、合成スクワラン、植物性スクワラン、ポリイソブチレン、ポリブテン等を挙げることができる。また、エステル油はエステル基を含有する液状の油剤であり、例えばホホバ油、2−エチルヘキサン酸セチル、イソノナン酸イソノニル、イソノナン酸イソトリデシル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、ミリスチン酸オクチルドデシル、イソノナン酸イソトリデシル、オレイン酸エチル、トリ2−エチルヘキサン酸グリセリル、ジカプリン酸プロピレングリコール、ジカプリン酸ネオペンチルグリコール、トリイソステアリン酸ポリグリセリル−2、トリベヘン酸グリセリル、リンゴ酸ジイソステアリル、p−アミノ安息香酸エチルヘキシルジメチル、サリチル酸エチルヘキシル、メトキシケイ皮酸エチルヘキシル、酢酸トコフェロール、オリーブ油、ヒマシ油、ミンク油、マカデミアンナッツ油、メドウフォーム油、カメリア油、ローズヒップ油、コメヌカ油、アボカド油等を例示することができる。 The oil agent that is liquid at 25 ° C. selected from the group consisting of the hydrocarbon oil and ester oil of component (D) used in the present invention is not particularly limited, and is a hydrocarbon that is liquid at 25 ° C. that can be used in cosmetics and skin external preparations. Any oil or ester oil can be used. Regardless of the origin of the component oil (D), such as animal oil, vegetable oil, and synthetic oil, hydrocarbon oils include, for example, liquid paraffin, heavy liquid isoparaffin (hydrogenated polyisobutene), light liquid isoparaffin, dodecane, isododecane, tetradecane, and isotetradecane. Hexadecane, isohexadecane, squalane, synthetic squalane, vegetable squalane, polyisobutylene, polybutene and the like. The ester oil is a liquid oil containing an ester group, such as jojoba oil, cetyl 2-ethylhexanoate, isononyl isononanoate, isotridecyl isononanoate, isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, isononanoic acid Isotridecyl, ethyl oleate, glyceryl tri-2-ethylhexanoate, propylene glycol dicaprate, neopentyl glycol dicaprate, polyglyceryl triisostearate, glyceryl tribehenate, diisostearyl malate, ethylhexyldimethyl p-aminobenzoate, Ethyl hexyl salicylate, ethyl hexyl methoxycinnamate, tocopherol acetate, olive oil, castor oil, mink oil, macadamia nut oil, meadow foam oil Camellia oil, rose hip oil, rice bran oil can be exemplified avocado oil.
本発明において成分(D)として、特に分子量が200〜1000の炭化水素油またはエステル油が好ましく、適用後のうるおい感、べたつきのなさなど、後肌の感触がより良好な水中油乳化型の化粧料等を得ることができる。成分(D)において、分子量が200〜1000のものとしては、例えばイソヘキサデカン、軽質流動イソパラフィン、流動パラフィン、重質流動イソパラフィン、スクワラン、合成スクワラン、植物性スクワラン、ジカプリン酸プロピレングリコール、ジカプリル酸プロピレングリコール、ジカプリン酸ネオペンチルグリコール、イソノナン酸イソノニル、イソノナン酸イソトリデシル、2−エチルヘキサン酸セチル、トリ2−エチルヘキサン酸グリセリル、トリイソステアリン酸ポリグリセリル−2、メトキシケイ皮酸エチルヘキシル、α−オレフィンオリゴマー(水添ポリデセン)等が挙げられる。なお、分子量の値は上記成分の分子の化学構造式に基づき、分子を構成する原子の原子量の和として求めることができるが、軽質流動イソパラフィンや流動パラフィン、重質流動イソパラフィン、α−オレフィンオリゴマー等、分子量の異なる成分の混合物である場合には、これら成分の炭素数の分布を求め、各成分の分子量に換算した値が200〜1000の範囲内に入る成分が該混合物の90質量%以上であれば、本発明における分子量が200〜1000の炭化水素油またはエステル油であるとする。なお、医薬部外品原料規格に収載される軽質流動イソパラフィン、流動パラフィン、重質流動イソパラフィン、α−オレフィンオリゴマーは、何れも本発明の成分(D)に該当する。 In the present invention, as the component (D), a hydrocarbon oil or ester oil having a molecular weight of 200 to 1000 is particularly preferable, and an oil-in-water emulsion type makeup with a better feeling of the back skin such as a moist feeling after application and non-stickiness. Fees etc. can be obtained. Component (D) having a molecular weight of 200 to 1000 includes, for example, isohexadecane, light liquid isoparaffin, liquid paraffin, heavy liquid isoparaffin, squalane, synthetic squalane, vegetable squalane, propylene glycol dicaprate, propylene glycol dicaprylate , Neopentyl glycol dicaprate, isononyl isononanoate, isotridecyl isononanoate, cetyl 2-ethylhexanoate, glyceryl tri-2-ethylhexanoate, polyglyceryl-2 triisostearate, ethylhexyl methoxycinnamate, α-olefin oligomer (hydrogenated) Polydecene) and the like. The molecular weight value can be obtained as the sum of the atomic weights of the atoms constituting the molecule based on the chemical structural formula of the molecule of the above component. Light liquid isoparaffin, liquid paraffin, heavy liquid isoparaffin, α-olefin oligomer, etc. In the case of a mixture of components having different molecular weights, the carbon number distribution of these components is obtained, and the component whose value converted to the molecular weight of each component falls within the range of 200 to 1000 is 90% by mass or more of the mixture. If there is, it is assumed that it is a hydrocarbon oil or ester oil having a molecular weight of 200 to 1000 in the present invention. The light liquid isoparaffin, liquid paraffin, heavy liquid isoparaffin, and α-olefin oligomer listed in the quasi-drug raw material standard all correspond to the component (D) of the present invention.
本発明において成分(D)の含有量は特に限定されないが、成分(D)の肌効果を十分に実感できる量として、好ましくは化粧料または皮膚外用剤の全量に対し0.1質量%〜80質量%であり、より好ましくは0.5質量%〜50質量%、特に好ましくは1質量%〜20質量%である。 In the present invention, the content of the component (D) is not particularly limited, but is preferably 0.1% by mass to 80% with respect to the total amount of the cosmetic or the external preparation for skin, as an amount that can sufficiently realize the skin effect of the component (D). % By mass, more preferably 0.5% by mass to 50% by mass, and particularly preferably 1% by mass to 20% by mass.
本発明においては、上記成分に加え、さらに成分(E)の25℃でペースト状の油剤を含有することにより、適用時の肌なじみ(密着感)が向上し、浸透感やうるおい感もさらによくなるため好ましい。ここでペースト状油剤とは、ブルックフィールド型回転粘度計による25℃の粘度が10,000mPa・s以上で、該粘度計の測定限界100,000mPa・sを超えるものは、30℃の稠度(JIS−K−2220準拠、稠度計、30gアルミニウムコーン使用、落下5秒後の値)が150より大きい(柔らかい)油剤をいう。本発明においては特に25℃で流動しない油剤が好ましい。成分(E)の油剤は、25℃でペースト状であれば特に限定されず、化粧品や皮膚外用剤に使用可能なペースト状油剤であれば何れのものも使用可能である。成分(E)としては例えば、ジペンタエリトリット脂肪酸(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)エステル、ワセリン、モノステアリン酸硬化ヒマシ油、モノヒドロキシステアリン酸硬化ヒマシ油、ヒドロキシステアリン酸コレステリル、ヒドロキシステアリン酸フィトステリル、オレイン酸フィトステリル、N−ラウロイル−L−グルタミン酸−ジ(コレステリル・ベヘニル・オクチルドデシル)、N−ラウロイル−L−グルタミン酸−ジ(フィトステリル・ベヘニル・オクチルドデシル)、ダイマージリノール酸(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル)、アルコシキ変性シリコーン、アルキル変性シリコーン等が挙げられるが、肌なじみ向上に特に寄与する油剤として、ジペンタエリトリット脂肪酸(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)エステル、ヒドロキシステアリン酸コレステリル、ヒドロキシステアリン酸フィトステリル、オレイン酸フィトステリル、シア脂、N−ラウロイル−L−グルタミン酸−ジ(コレステリル・ベヘニル・オクチルドデシル)、N−ラウロイル−L−グルタミン酸−ジ(フィトステリル・ベヘニル・オクチルドデシル)を使用することがより好ましい。 In the present invention, in addition to the above components, the addition of a paste-like oil agent at 25 ° C. of component (E) improves skin familiarity (adhesion feeling) at the time of application, and further improves the penetration feeling and moisture feeling. Therefore, it is preferable. Here, the pasty oil agent has a viscosity at 25 ° C. of 10,000 mPa · s or more measured by a Brookfield type rotational viscometer and exceeds a measurement limit of 100,000 mPa · s of the viscometer. -K-2220 conformity, consistency meter, use of 30 g aluminum cone, value after 5 seconds of dropping) refers to an oil agent with a value greater than 150 (soft). In the present invention, an oil that does not flow at 25 ° C. is particularly preferable. The oil of component (E) is not particularly limited as long as it is in a paste form at 25 ° C. Any oil can be used as long as it is a paste oil that can be used in cosmetics and external preparations for skin. Examples of the component (E) include dipentaerythritol fatty acid (hydroxystearic acid / stearic acid / rosin acid) ester, petrolatum, monostearic acid hydrogenated castor oil, monohydroxystearic acid hydrogenated castor oil, cholesteryl hydroxystearate, hydroxystearic acid Phytosteryl acid, phytosteryl oleate, N-lauroyl-L-glutamic acid-di (cholesteryl behenyl octyldodecyl), N-lauroyl-L-glutamic acid-di (phytosteryl behenyl octyldodecyl), dimerlinoleic acid (phytosteryl / Isostearyl / cetyl / stearyl / behenyl), alkoxy-modified silicone, alkyl-modified silicone, and the like. Fatty acid (hydroxystearic acid / stearic acid / rosin acid) ester, cholesteryl hydroxystearate, phytosteryl hydroxystearate, phytosteryl oleate, shea butter, N-lauroyl-L-glutamic acid-di (cholesteryl behenyl octyldodecyl), N It is more preferable to use -lauroyl-L-glutamic acid-di (phytosteryl, behenyl, octyldodecyl).
成分(E)は1種を単独で、または2種以上を組み合わせて用いることができ、その含有量は特に限定されないが、0.01質量%〜10質量%が好ましく、0.05質量%〜5質量%がより好ましく、とりわけ0.1質量%〜2質量%が好ましい。 A component (E) can be used individually by 1 type or in combination of 2 or more types, Although the content is not specifically limited, 0.01 mass%-10 mass% are preferable, 0.05 mass%- 5 mass% is more preferable, and 0.1 mass%-2 mass% are especially preferable.
本発明において、さらに成分(F)としてグリセリンのポリオキシアルキレン誘導体、ポリグリセリンのポリオキシアルキレン誘導体またはメチルグルコシドのポリオキシアルキレン誘導体を含有することにより、肌への浸透感、うるおい感がさらに向上する。ここで、ポリオキシアルキレン誘導体としては、グリセリン、ポリグリセリンまたはメチルグルコシドに酸化アルキレンを付加重合させたエーテル化合物が好ましい。成分(F)としては具体的には、例えばポリオキシエチレングリセリルエーテル、ポリオキシプロピレングリセリルエーテル、ポリオキシプロピレンポリグリセリルエーテル、ポリオキシエチレンメチルグルコシド、ポリオキシプロピレンメチルグルコシド等を挙げることができるが、これらのうちアルキレンオキサイドの付加モル数が2〜50のポリオキシエチレングリセリルエーテル、ポリオキシプロピレンジグリセリルエーテル、ポリオキシエチレンメチルグルコシドまたはポリオキシプロピレンメチルグルコシドが特に好ましい。 In the present invention, by containing a polyoxyalkylene derivative of glycerin, a polyoxyalkylene derivative of polyglycerin or a polyoxyalkylene derivative of methyl glucoside as the component (F), the permeation feeling and moisture feeling on the skin are further improved. . Here, the polyoxyalkylene derivative is preferably an ether compound obtained by addition polymerization of alkylene oxide to glycerin, polyglycerin or methyl glucoside. Specific examples of the component (F) include polyoxyethylene glyceryl ether, polyoxypropylene glyceryl ether, polyoxypropylene polyglyceryl ether, polyoxyethylene methyl glucoside, polyoxypropylene methyl glucoside, and the like. Of these, polyoxyethylene glyceryl ether, polyoxypropylene diglyceryl ether, polyoxyethylene methyl glucoside or polyoxypropylene methyl glucoside having an addition mole number of alkylene oxide of 2 to 50 is particularly preferred.
成分(F)は1種を単独で、または2種以上を組み合わせて用いることができ、その含有量は特に限定されないが、0.1質量%〜30質量%が好ましく、1質量%〜10質量%がより好ましい。 A component (F) can be used individually by 1 type or in combination of 2 or more types, The content is not specifically limited, However, 0.1 mass%-30 mass% are preferable, 1 mass%-10 mass % Is more preferable.
本発明の化粧料または皮膚外用剤は、系のpHを限定するものではないが、6を超える中性域のpH、とりわけpH7付近において、十分な安定性および後肌の化粧膜の柔軟性の効果を良好に享受することができ、特に好ましい。 The cosmetic or external preparation for skin of the present invention does not limit the pH of the system. However, the cosmetic or the external preparation of the present invention has sufficient stability and flexibility of the cosmetic film on the back skin at a pH in the neutral range exceeding 6, especially around pH 7. The effect can be enjoyed satisfactorily and is particularly preferable.
本発明の化粧料または皮膚外用剤においては、その粘度(25℃)がブルックフィールド型回転粘度計をによる測定で20,000mPa・sを超えると、ポンプ式ディスペンサー容器の吐出口から吐出しにくくなる傾向がある。ポンプ式ディスペンサー容器は取り扱いが簡便で吐出量の調整もし易いため好まれており、本発明の化粧料等に対しても好ましい容器であるが、ポンプ吐出口からの吐出をスムーズにするためには、本発明の化粧料等の粘度(25℃)を、20,000mPa・sを超えない、比較的低粘度のものとすることが好ましい。 In the cosmetic or skin external preparation of the present invention, when the viscosity (25 ° C.) exceeds 20,000 mPa · s as measured with a Brookfield rotary viscometer, it becomes difficult to discharge from the discharge port of the pump-type dispenser container. Tend. The pump-type dispenser container is preferred because it is easy to handle and the discharge amount can be easily adjusted, and is also preferred for the cosmetics of the present invention, but for smooth discharge from the pump discharge port. The viscosity (25 ° C.) of the cosmetics of the present invention is preferably a relatively low viscosity that does not exceed 20,000 mPa · s.
本発明の化粧料または皮膚外用剤の製造方法は、例えばマイクロフルイダイザー等の高圧乳化機を用いて処理することもできる。高圧乳化機を用いることで、例えば25℃で1mPa・s〜1,000mPa・s(ブルックフィールド型回転粘度計)というような特に低粘度の乳化型化粧料等とすることができるため、肌適用時にみずみずしい感触と肌への高い浸透感を得ることができ、好ましい。このような、特に低粘度の水中油乳化型の化粧料等にした場合には、低粘度域での乳化安定性を高めるために乳化滴の平均粒子径を1μmを超えないようにすることが好ましく、0.01μm〜0.8μmとすることがより好ましい。さらに、乳化滴の最大粒子径が1μmを超えないようにすることが特に好ましい。乳化滴の平均粒子径は、例えばコールターカウンター(ベックマン・コールター社製:サブミクロン粒子アナライザーN5)等による測定で求めることができる。また、乳化滴の最大粒子径は、同測定器で求めることができるが、粒子径が1μmを超えるものの有無などは、例えば目盛を付したスライドグラス等を用い、顕微鏡による目視によっても調べることができる。 The method for producing the cosmetic or the external preparation for skin of the present invention can also be processed using a high-pressure emulsifier such as a microfluidizer. By using a high-pressure emulsifier, for example, a low-viscosity emulsion-type cosmetic such as 1 mPa · s to 1,000 mPa · s (Brookfield rotary viscometer) at 25 ° C. can be applied to the skin. Sometimes it is possible to obtain a fresh feeling and a high penetration into the skin, which is preferable. When such a low-viscosity oil-in-water emulsified cosmetic is used, the average particle size of the emulsified droplets should not exceed 1 μm in order to improve the emulsion stability in the low viscosity region. Preferably, it is more preferable to set it as 0.01 micrometer-0.8 micrometer. Furthermore, it is particularly preferable that the maximum particle size of the emulsified droplets does not exceed 1 μm. The average particle diameter of the emulsified droplets can be determined by measurement using, for example, a Coulter counter (manufactured by Beckman Coulter, Inc .: submicron particle analyzer N5). The maximum particle size of the emulsified droplets can be determined with the same measuring device. The presence or absence of a particle size exceeding 1 μm can be examined by visual observation with a microscope using, for example, a slide glass with a scale. it can.
本発明の化粧料または皮膚外用剤には、本発明の効果を妨げない範囲内で通常の化粧料または皮膚外用剤に配合される他の成分を配合することができる。他の成分としては、例えば、次に示す成分で、本発明の成分(A)ないし成分(F)に含まれないもの、即ち、固形油、植物脂、ジメチルシリコーン、高分子量シリコーン、アミノ変性シリコーン、ポリオキシアルキレン変性シリコーン、フッ素変性シリコーン、多価アルコール変性シリコーン、一価低級アルコール、多価アルコール、高級アルコール、高級脂肪酸、有機粉体、無機粉体、水溶性高分子、皮膜形成剤、陰イオン性界面活性剤、非イオン性界面活性剤、陽イオン性界面活性剤、両性界面活性剤、水性増粘剤、油性ゲル化剤、有機変性粘土鉱物、水膨潤性粘土鉱物、増粘多糖類、油性樹脂、紫外線吸収剤、紫外線遮蔽剤、防腐剤、抗菌剤、抗炎症剤、香料、抗酸化剤、pH調整剤、キレート剤、水溶性ビタミン類、油溶性ビタミン類、セラミド類、アミノ酸類、ムコ多糖類、植物エキス、植物性脂肪等を配合することができる。 The cosmetic or the external preparation for skin of the present invention can be blended with other components that are blended with the normal cosmetic or external preparation for skin within the range not impeding the effects of the present invention. As other components, for example, the following components which are not included in the components (A) to (F) of the present invention, that is, solid oil, vegetable fat, dimethyl silicone, high molecular weight silicone, amino-modified silicone , Polyoxyalkylene-modified silicone, fluorine-modified silicone, polyhydric alcohol-modified silicone, monohydric lower alcohol, polyhydric alcohol, higher alcohol, higher fatty acid, organic powder, inorganic powder, water-soluble polymer, film forming agent, shade Ionic surfactants, nonionic surfactants, cationic surfactants, amphoteric surfactants, aqueous thickeners, oily gelling agents, organically modified clay minerals, water-swelling clay minerals, thickening polysaccharides , Oil-based resin, UV absorber, UV screening agent, antiseptic, antibacterial agent, anti-inflammatory agent, fragrance, antioxidant, pH adjuster, chelating agent, water-soluble vitamins, oil-soluble vitamin S, ceramides, amino acids, mucopolysaccharides, plant extracts, can be blended vegetable fats like.
本発明の化粧料または皮膚外用剤は、例えば化粧水、乳液、クリーム、アイクリーム、美容液、マッサージ料、パック料、ハンドクリーム、ボディクリーム、クレンジング料、頭皮ケア料等の皮膚用の化粧料や医薬部外品等として実施することができる。肌への適用の方法は限定されないが、当該化粧料等を手や指で直接肌に塗布する方法、不織布等に含浸させて塗布する方法、噴射剤と共に耐圧容器に収容しスプレー状またはフォーム状に肌上に吐出させ塗布する方法、ノンガスタイプのポンプスプレー容器に収容し肌上に噴霧する方法等を挙げることができる。 The cosmetics or skin external preparations of the present invention are skin cosmetics such as lotions, emulsions, creams, eye creams, cosmetics, massages, packs, hand creams, body creams, cleansings, and scalp cares. Or as a quasi-drug. The method of application to the skin is not limited, but the method of directly applying the cosmetic or the like to the skin by hand or finger, the method of applying it by impregnating a non-woven fabric, etc. And a method of spraying on the skin and applying to the skin, and a method of storing in a non-gas type pump spray container and spraying on the skin.
次に実施例を挙げて本発明を更に詳細に説明するが、本発明はこれらにより限定されるものではない。 EXAMPLES Next, although an Example is given and this invention is demonstrated still in detail, this invention is not limited by these.
(本発明品1〜7および比較品1〜6:水中油乳化型化粧水)
表1に示す組成および下記製造方法にて水中油乳化型の化粧水を調製し、各試料について下記評価方法により評価、判定を行った。結果を表1に併記する。
(Invention products 1-7 and comparative products 1-6: oil-in-water emulsified lotion)
An oil-in-water emulsified lotion was prepared by the composition shown in Table 1 and the following production method, and each sample was evaluated and judged by the following evaluation method. The results are also shown in Table 1.
注1:LP70H(日本精化社製)
注2:レシノールS−10(日光ケミカルズ社製)
注3:KLEAROL WHITE MINERAL OIL(SONNEBORN,LLC社製)
注4:パールルリーム18(日油社製)
注5:コスモール168ARV(日清オイリオグループ社製)
Note 1: LP70H (Nippon Seika Co., Ltd.)
Note 2: Resinol S-10 (Nikko Chemicals)
Note 3: KLEAROL WHITE MINAL OIL (SONNEBORN, LLC)
Note 4: Pearl Lureme 18 (manufactured by NOF Corporation)
Note 5: Cosmall 168ARV (Nisshin Oillio Group)
(製造方法)
A:成分(2)〜(5)および成分(14)、(15)を70℃に加熱し、均一に混合する。
B:成分(6)〜(11)および成分(19)を70℃に加熱し、均一に混合する。
C:AにBを添加して、70℃にてゲルを調合する。
D:Cに70℃に加熱した成分(20)の一部を添加して乳化する。
E:Dを35℃まで冷却し、マイクロフルイダイザーにて処理する。
F:成分(20)の残部に、成分(1)、(12)、(13)、(16)、(17)を溶解し、Eを加えて均一に混合する。
G:Fに成分(18)を添加しpHを7に調整して、顕微鏡を用いた目視の範囲内で粒子径が1μmを超える乳化滴を有さない水中油乳化型化粧水を得た。
(Production method)
A: Components (2) to (5) and components (14) and (15) are heated to 70 ° C. and mixed uniformly.
B: Components (6) to (11) and component (19) are heated to 70 ° C. and mixed uniformly.
C: B is added to A and a gel is prepared at 70 ° C.
D: A part of the component (20) heated to 70 ° C. is added to C and emulsified.
E: D is cooled to 35 ° C. and treated with a microfluidizer.
F: Components (1), (12), (13), (16), and (17) are dissolved in the remainder of the component (20), and E is added and mixed uniformly.
G: The component (18) was added to F and the pH was adjusted to 7. Thus, an oil-in-water emulsified lotion having no emulsified droplets with a particle diameter exceeding 1 μm within the range visually observed using a microscope was obtained.
(評価方法)
10名の専門パネルに各試料を使用してもらい、肌への適用時の浸透感、化粧膜の柔軟さ(硬さの抑制効果)、適用後の肌のうるおい感、べたつきのなさの各評価項目について、下記(イ)5段階評価基準により評点を付してもらった。そして、全パネルの評点の平均値を下記(ロ)4段階判定基準に従い判定した。また、経時安定性については、各試料を40℃の高温環境下に1箇月間静置した後、目視にて変化の有無、程度を確認して、下記(ハ)4段階判定基準により判定した。
(Evaluation method)
Each sample was used by 10 professional panels, and each evaluation of penetration feeling when applied to skin, softness of makeup film (inhibition effect on hardness), moisture feeling of applied skin, and non-stickiness The items were scored according to the following (b) 5-step evaluation criteria. And the average value of the score of all the panels was determined in accordance with the following (b) 4-step criteria. The stability over time was determined by the following (c) four-step criteria after each sample was left in a high temperature environment of 40 ° C. for one month, and the presence / absence and degree of change were visually confirmed. .
(イ)5段階評価基準
(評点): (評価)
5点 : 強く感じられる
4点 : 感じられる
3点 : 少し感じられる
2点 : あまり感じられない
1点 : 全く感じられない
(B) Five-level evaluation criteria (score): (Evaluation)
5 points: 4 points felt strongly: 3 points felt: 2 points felt a little: 1 point not felt so much: Not felt at all
(ロ)4段階判定基準
(評点の平均値) :(判定)
4.5以上 : ◎
3.5以上、4.5未満 : ○
2.5以上、3.5未満 : △
2.5未満 : ×
(B) Four-step criteria (average score): (Judgment)
4.5 or more: ◎
3.5 or more and less than 4.5: ○
2.5 or more and less than 3.5: △
Less than 2.5: ×
(ハ)4段階判定基準
(40℃、1箇月後の変化の度合い):(判定)
変化がなく問題ない : ◎
クリーミングがごくわずかである : ○
明らかにクリーミングがある : △
分離している : ×
(C) 4-step criteria (degree of change after 40 ° C, 1 month): (Judgment)
No change and no problem: ◎
There is very little creaming: ○
Clearly there is creaming: △
Separated: ×
表1の結果から明らかなように、本発明品1〜7の水中油乳化型化粧水は、肌適用時の浸透感、化粧膜の柔軟さ、適用後の肌のうるおい感、べたつきのなさ、経時安定性の全ての項目において良好な結果を示し、トラネキサム酸由来の硬さを感じることもなく、pH7の中性域においても十分な経時安定性を示す、優れた品質を有するものであることが立証された。一方、リゾリン脂質とリン脂質を併用しない比較品1、2や、リゾリン脂質もリン脂質も使用せず他の非イオン性界面活性剤や陰イオン性界面活性剤で乳化した比較品3、4は、望まれる経時安定性が得られず、さらにトラネキサム酸由来の化粧膜の硬さを十分に解消できないため、柔軟な化粧膜を得ることができなかった。また、成分(D)以外の油剤を用いた比較品5や成分(D)を含有しない比較品6は後肌のうるおい感が得られず、浸透感やべたつきのなさにおいてもよい結果が得られなかった。 As is apparent from the results in Table 1, the oil-in-water emulsified lotions of the products 1 to 7 of the present invention have a penetrating feeling when applied to the skin, the softness of the cosmetic film, the moist feeling of the skin after application, and no stickiness. It has good results in all items of stability over time, does not feel the hardness derived from tranexamic acid, has sufficient quality even in the neutral range of pH 7, and has excellent quality. Was proved. On the other hand, comparative products 1 and 2 which do not use lysophospholipid and phospholipid together, and comparative products 3 and 4 emulsified with other nonionic surfactants or anionic surfactants without using lysophospholipids or phospholipids The desired stability over time could not be obtained, and the hardness of the cosmetic film derived from tranexamic acid could not be sufficiently eliminated, so that a flexible cosmetic film could not be obtained. Moreover, the comparative product 5 using the oil agent other than the component (D) and the comparative product 6 not containing the component (D) do not have a moist feeling of the back skin, and good results are obtained even in the sense of penetration and non-stickiness. There wasn't.
(本発明品8)
下記の組成および製造方法にて、水中油乳化型の乳液を調製した。
(成分)・・・・・(質量%)
1.水素添加卵黄リゾリン脂質・・・・・1
2.水素添加大豆リン脂質・・・・・2
3.酢酸トコフェロール・・・・・0.1
4.オレイン酸エチル・・・・・2
5.2−エチルヘキサン酸セチル・・・・・5
6.ヒドロキシステアリン酸コレステリル・・・・・1
7.N−ラウロイル−L−グルタミン酸−ジ(フィトステリル・ベヘニル・オクチルドデシル)・・・・・1
8.流動パラフィン(注3)・・・・・5
9.セタノール・・・・・1
10.親油型モノステアリン酸グリセリル・・・・・0.5
11.プロピレングリコール・・・・・10
12.グリセリン・・・・・10
13.ジグリセリン・・・・・5
14.ポリオキシエチレン(10E.O.)メチルグルコシド・・・・・5
15.トラネキサム酸・・・・・2
16.ピロ亜硫酸ナトリウム・・・・・0.01
17.リン酸一水素ナトリウム・・・・・0.1
18.リン酸二水素ナトリウム・・・・・0.1
19.防腐剤・・・・・適量
20.N−ステアロイル−L−グルタミン酸ナトリウム・・・・・0.1
21.エタノール・・・・・5
22.カルボキシビニルポリマー・・・・・0.1
23.水酸化ナトリウム・・・・・0.03
24.ヒアルロン酸ナトリウム・・・・・0.1
25.香料・・・・・0.1
26.精製水・・・・・残量
(Invention product 8)
An oil-in-water emulsion type emulsion was prepared by the following composition and production method.
(Component) ... (mass%)
1. Hydrogenated egg yolk lysophospholipid 1
2. Hydrogenated soybean phospholipid 2
3. Tocopherol acetate ... 0.1
4). Ethyl oleate 2
5. Cetyl 2-ethylhexanoate 5
6). Cholesteryl hydroxystearate 1
7). N-lauroyl-L-glutamic acid-di (phytosteryl, behenyl, octyldodecyl) 1
8). Liquid paraffin (Note 3) 5
9. Setanol 1
10. Lipophilic glyceryl monostearate: 0.5
11. Propylene glycol ... 10
12 Glycerin ... 10
13. Diglycerin 5
14 Polyoxyethylene (10E.O.) methyl glucoside 5
15. Tranexamic acid 2
16. Sodium pyrosulfite 0.01
17. Sodium monohydrogen phosphate ... 0.1
18. Sodium dihydrogen phosphate ... 0.1
19. Preservative: appropriate amount 20. N-stearoyl-sodium L-glutamate 0.1
21. Ethanol 5
22. Carboxyvinyl polymer ... 0.1
23. Sodium hydroxide 0.03
24. Sodium hyaluronate ... 0.1
25. Perfume ... 0.1
26. Purified water
(製造方法)
A:成分(1)〜(13)を70℃で加熱溶解する。
B:成分(20)、(26)を70℃に加熱し、Aに添加し乳化する。
C:成分(14)〜(19)および成分(21)〜(24)をBに添加し混合する。
D:Cを冷却して、成分(25)を添加し乳液を得た。
(Production method)
A: Components (1) to (13) are dissolved by heating at 70 ° C.
B: Components (20) and (26) are heated to 70 ° C., added to A and emulsified.
C: Components (14) to (19) and components (21) to (24) are added to B and mixed.
D: C was cooled and component (25) was added to obtain an emulsion.
本発明品8の乳液は、適用後の肌にトラネキサム酸由来の硬さを感じることがなく、肌への浸透感とうるおい感があり、べたつきの少ない優れた品質を有するものであった。また、経時的にも分離やクリーミングが見られず、安定性も優れたものであった。 The emulsion of the product 8 of the present invention did not feel the hardness derived from tranexamic acid on the skin after application, had a sense of penetration into the skin and a moist feeling, and had excellent quality with little stickiness. Further, separation and creaming were not observed over time, and the stability was excellent.
(本発明品9)
下記の組成および製造方法にて、クリームを調製した。
(成分)・・・・・(質量%)
1.水素添加大豆リゾリン脂質・・・・・1
2.コレステロール複合化水素添加大豆リン脂質(注6)・・・・・1
3.スクワラン・・・・・5
4.重質流動イソパラフィン・・・・・2
5.ジカプリン酸ネオペンチルグリコール・・・・・5
6.トリ2−エチルヘキサン酸グリセリル・・・・・5
7.オレイン酸フィトステリル・・・・・1
8.シア脂・・・・・1
9.セラミド−2・・・・・0.01
10.セトステアリルアルコール・・・・3
11.ベヘニルアルコール・・・・・2
12.ジプロピレングリコール・・・・・20
13.モノオレイン酸ポリオキシエチレンソルビタン・・・・・0.5
14.セスキオレイン酸ソルビタン・・・・・0.5
15.ポリオキシプロピレン(10P.O.)メチルグルコシド・・・・・5
16.トラネキサム酸・・・・・2
17.ピロ亜硫酸ナトリウム・・・・・0.01
18.リン酸一水素ナトリウム・・・・・0.1
19.リン酸二水素ナトリウム・・・・・0.1
20.防腐剤・・・・・適量
21.アクリル酸/アクロイルジメチルタウリンナトリウムコポリマー・・・・・1
22.ヒドロキシプロピルメチルセルロース・・・・・0.1
23.L−セリン・・・・・0.1
24.L−アルギニン・・・・・0.1
25.アスコルビン酸2−グルコシド・・・・・0.1
26.精製水・・・・・残量
注6:水素添加大豆リン脂質を80質量%含む
(Invention product 9)
A cream was prepared by the following composition and production method.
(Component) ... (mass%)
1. Hydrogenated soybean lysophospholipid ... 1
2. Cholesterol complexed hydrogenated soybean phospholipid (Note 6) 1
3. Squalane ... 5
4). Heavy liquid isoparaffin 2
5. Neopentyl glycol dicaprate 5
6). Glyceryl tri-2-ethylhexanoate 5
7). Phytosteryl oleate 1
8). Shea fat ...... 1
9. Ceramide-2 ... 0.01
10. Cetostearyl alcohol ・ ・ ・ 3
11. Behenyl alcohol 2
12 Dipropylene glycol 20
13. Monooleic acid polyoxyethylene sorbitan ... 0.5
14 Sorbitan sesquioleate ... 0.5
15. Polyoxypropylene (10P.O.) methyl glucoside 5
16. Tranexamic acid 2
17. Sodium pyrosulfite 0.01
18. Sodium monohydrogen phosphate ... 0.1
19. Sodium dihydrogen phosphate ... 0.1
20. Preservative: appropriate amount 21. Acrylic acid / Acroyldimethyltaurine sodium copolymer 1
22. Hydroxypropyl methylcellulose ... 0.1
23. L-Serine 0.1
24. L-Arginine ... 0.1
25. Ascorbic acid 2-glucoside ... 0.1
26. Purified water: remaining amount Note 6: Contains 80% by mass of hydrogenated soybean phospholipid
(製造方法)
A:成分(1)〜(14)を70℃で加熱溶解する。
B:成分(26)を70℃に加熱し、Aに添加し乳化する。
C:Bを冷却して、成分(15)〜(25)を添加混合しクリームを得た。
(Production method)
A: Components (1) to (14) are dissolved by heating at 70 ° C.
B: The component (26) is heated to 70 ° C., added to A and emulsified.
C: B was cooled, and components (15) to (25) were added and mixed to obtain a cream.
本発明品9のクリームは、適用後の肌にトラネキサム酸由来の硬さを感じることがなく、肌への浸透感とうるおい感があり、べたつきの少ない優れた品質を有するものであった。また、経時的にも分離やクリーミングが見られず、安定性も優れたものであった。 The cream of the product 9 of the present invention did not feel the hardness derived from tranexamic acid on the skin after application, had a penetration feeling into the skin and a moist feeling, and had excellent quality with little stickiness. Further, separation and creaming were not observed over time, and the stability was excellent.
(本発明品10)
下記の組成および製造方法にて、日焼け止め料を調製した。
(成分)・・・・・(質量%)
1.水素添加大豆リゾリン脂質・・・・・0.85
2.フィトステロール複合化水素添加大豆リン脂質(注7)・・・・・0.5
3.ステアリン酸・・・・・0.5
4.軽質流動イソパラフィン・・・・・5
5.イソヘキサデカン・・・・・5
6.ジカプリン酸プロピレングリコール・・・・・5
7.メトキシケイ皮酸エチルヘキシル・・・・・5
8.ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル・・・・・5
9.ダイマージリノール酸(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル)・・・・・1
10.ステアリルアルコール・・・・2
11.1,3−ブチレングリコール・・・・・2
12.ジプロピレングリコール・・・・・20
13.ポリオキプロピレン(9E.O.)ジグリセリルエーテル・・・・・10
14.水酸化ナトリウム・・・・・0.1
15.トラネキサム酸・・・・・2
16.ピロ亜硫酸ナトリウム・・・・・0.01
17.リン酸一水素ナトリウム・・・・・0.1
18.リン酸二水素ナトリウム・・・・・0.1
19.防腐剤・・・・・適量
20.アルキル変性カルボキシビニルポリマー・・・・・0.2
21.キサンタンガム・・・・・0.1
22.ジメチコン処理微粒子酸化チタン・・・・・5
23.香料・・・・・0.1
24.精製水・・・・・残量
注7:水素添加大豆リン脂質を85質量%含む
(Invention product 10)
Sunscreen was prepared by the following composition and manufacturing method.
(Component) ... (mass%)
1. Hydrogenated soybean lysophospholipid ... 0.85
2. Phytosterol complex hydrogenated soybean phospholipids (Note 7) 0.5
3. Stearic acid 0.5
4). Light liquid isoparaffin 5
5. Isohexadecane 5
6). Propylene glycol dicaprate 5
7). Ethyl hexyl methoxycinnamate 5
8). Diethylaminohydroxybenzoyl hexyl benzoate 5
9. Dimer linoleic acid (phytosteryl / isostearyl / cetyl / stearyl / behenyl) ... 1
10. Stearyl alcohol ... 2
11.1,3-butylene glycol 2
12 Dipropylene glycol 20
13. Polyoxypropylene (9E.O.) diglyceryl ether ... 10
14 Sodium hydroxide ... 0.1
15. Tranexamic acid 2
16. Sodium pyrosulfite 0.01
17. Sodium monohydrogen phosphate ... 0.1
18. Sodium dihydrogen phosphate ... 0.1
19. Preservative: appropriate amount 20. Alkyl-modified carboxyvinyl polymer ... 0.2
21. Xanthan gum ... 0.1
22. Dimethicone-treated fine particle titanium oxide 5
23. Perfume ... 0.1
24. Purified water
Note 7: Contains 85% by mass of hydrogenated soybean phospholipid
(製造方法)
A:成分(1)〜(14)を70℃で加熱溶解する。
B:成分(24)を70℃に加熱し、Aに添加し乳化する。
C:Bを冷却して、成分(15)〜(23)を添加混合し日焼け止め料を得た。
(Production method)
A: Components (1) to (14) are dissolved by heating at 70 ° C.
B: The component (24) is heated to 70 ° C., added to A and emulsified.
C: B was cooled, and components (15) to (23) were added and mixed to obtain a sunscreen.
本発明品10の日焼け止め料は、適用後の肌にトラネキサム酸由来の硬さを感じることがなく、肌への浸透感とうるおい感があり、べたつきの少ない優れた品質を有するものであった。また、経時的にも分離やクリーミングが見られず、安定性も優れたものであった。 The sunscreen of the product 10 of the present invention did not feel the hardness derived from tranexamic acid on the skin after application, had a penetration feeling into the skin and a moist feeling, and had excellent quality with little stickiness. . Further, separation and creaming were not observed over time, and the stability was excellent.
(本発明品11)
下記の組成および製造方法にて、化粧水を調製した。
(成分)・・・・・(質量%)
1.水素添加大豆リゾリン脂質・・・・・0.1
2.水素添加大豆リン脂質・・・・・0.3
3.グリセリン・・・・・5
4.1,3−ブチレングリコール・・・・・10
5.コメヌカ油・・・・・0.3
6.メドウフォーム油・・・・・0.3
7.オリーブスクワラン(注8)・・・・・0.4
8.モノステアリン酸硬化ヒマシ油・・・・・0.1
9.ポリオキシエチレン(4E.O.)ラウリルエーテルリン酸・・・・0.01
10.ポリオキシエチレン(10E.O.)メチルグルコシド・・・・・0.5
11.ポリオキプロピレン(14P.O.)ジグリセリルエーテル・・・・・0.5
12.トラネキサム酸・・・・・1
13.ピロ亜硫酸ナトリウム・・・・・0.01
14.リン酸一水素ナトリウム・・・・・0.1
15.リン酸二水素ナトリウム・・・・・0.1
16.防腐剤・・・・・適量
17.クインスシードエキス・・・・・1
18.ローズ水・・・・・10
19.グリチルリチン酸ジカリウム・・・・・0.01
20.香料・・・・・0.01
21.精製水・・・・・残量
注8:植物性スクワラン
(Invention product 11)
A lotion was prepared by the following composition and production method.
(Component) ... (mass%)
1. Hydrogenated soybean lysophospholipid ... 0.1
2. Hydrogenated soybean phospholipid ... 0.3
3. Glycerin 5
4.1,3-Butylene glycol ... 10
5. Rice bran oil ... 0.3
6). Meadow foam oil 0.3
7). Olive squalane (Note 8) 0.4
8). Monostearic acid hydrogenated castor oil ... 0.1
9. Polyoxyethylene (4E.O.) lauryl ether phosphoric acid 0.01
10. Polyoxyethylene (10E.O.) methyl glucoside 0.5
11. Polyoxypropylene (14 PO) diglyceryl ether 0.5
12 Tranexamic acid 1
13. Sodium pyrosulfite 0.01
14 Sodium monohydrogen phosphate ... 0.1
15. Sodium dihydrogen phosphate ... 0.1
16. Preservatives-appropriate amount 17. Quince Seed Extract 1
18. Rose water ... 10
19. Dipotassium glycyrrhizinate ... 0.01
20. Perfume ... 0.01
21. Purified water
Note 8: Plant-based squalane
(製造方法)
A:成分(1)〜(4)を70℃に加熱し、均一に混合する。
B:成分(5)〜(9)および成分(20)を70℃に加熱し、均一に混合する。
C:AにBを添加して、70℃にてゲルを調合する。
D:Cに70℃に加熱した成分(21)の一部を添加して乳化する。
E:Dを35℃まで冷却し、マイクロフルイダイザーにて処理する。
F:成分(21)の残部に、成分(10)〜(19)を溶解し、Eを加えて均一に混合して、顕微鏡を用いた目視の範囲内で粒子径が1μmを超える乳化滴を有さない化粧水を得た。
(Production method)
A: Components (1) to (4) are heated to 70 ° C. and mixed uniformly.
B: Components (5) to (9) and component (20) are heated to 70 ° C. and mixed uniformly.
C: B is added to A and a gel is prepared at 70 ° C.
D: A part of the component (21) heated to 70 ° C. is added to C and emulsified.
E: D is cooled to 35 ° C. and treated with a microfluidizer.
F: Components (10) to (19) are dissolved in the remainder of the component (21), E is added and mixed uniformly, and emulsified droplets having a particle diameter exceeding 1 μm within the range of visual observation using a microscope. A lotion that does not have was obtained.
本発明品11の化粧水は、適用後の肌にトラネキサム酸由来の硬さを感じることがなく、肌への浸透感とうるおい感があり、べたつきの少ない優れた品質を有するものであった。また、経時的にも分離やクリーミングが見られず、安定性も優れたものであった。 The lotion of the product 11 of the present invention did not feel the hardness derived from tranexamic acid on the skin after application, had a penetrating and moist feeling on the skin, and had excellent quality with little stickiness. Further, separation and creaming were not observed over time, and the stability was excellent.
Claims (8)
(A)トラネキサム酸、(B)リゾリン脂質、(C)リン脂質、(D)炭化水素油およびエステル油からなる群から選ばれる25℃で液状の油剤
を含有し、
前記成分(B)と前記成分(C)の含有質量比(B)/(C)が1/100〜10/1である
ことを特徴とする、水中油乳化型の化粧料または皮膚外用剤。 The following components (A) to (D),
(A) tranexamic acid, (B) lysophospholipid, (C) phospholipid, (D) containing a liquid oil at 25 ° C selected from the group consisting of hydrocarbon oil and ester oil ,
The oil- in- water emulsified cosmetic , wherein the content ratio (B) / (C) of the component (B) and the component (C) is 1/100 to 10/1. Skin external preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014223690A JP6364322B2 (en) | 2014-10-31 | 2014-10-31 | Cosmetic or skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014223690A JP6364322B2 (en) | 2014-10-31 | 2014-10-31 | Cosmetic or skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016088874A JP2016088874A (en) | 2016-05-23 |
JP6364322B2 true JP6364322B2 (en) | 2018-07-25 |
Family
ID=56018653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014223690A Active JP6364322B2 (en) | 2014-10-31 | 2014-10-31 | Cosmetic or skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6364322B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6504691B2 (en) * | 2014-11-13 | 2019-04-24 | ポーラ化成工業株式会社 | Liquid crystal emulsion composition |
JP6743382B2 (en) * | 2015-12-18 | 2020-08-19 | 味の素株式会社 | External skin preparation |
JP6823395B2 (en) * | 2016-07-15 | 2021-02-03 | 花王株式会社 | Underwater oil type emulsified cosmetic |
KR101953559B1 (en) * | 2018-09-03 | 2019-03-04 | 주식회사 펠리즈코스 | Oil-in-water type cosmetic composition and manufacturing method thereof |
JPWO2020158643A1 (en) * | 2019-01-29 | 2021-12-02 | 丸善製薬株式会社 | External agent |
JP6843917B2 (en) * | 2019-05-15 | 2021-03-17 | キユーピー株式会社 | Multivalent alcohol composition and viscous composition |
WO2021201136A1 (en) * | 2020-03-31 | 2021-10-07 | 株式会社コーセー | Oil-in-water type cosmetic emulsion preparation |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3821226B2 (en) * | 2002-07-17 | 2006-09-13 | 株式会社コーセー | Oil-in-water cosmetic |
JP2004352689A (en) * | 2003-05-30 | 2004-12-16 | Kose Corp | O/w-type emulsion cosmetic |
JP4732307B2 (en) * | 2006-11-20 | 2011-07-27 | 株式会社アンズコーポレーション | Nanoemulsion and cosmetics containing the same |
JP5384788B2 (en) * | 2006-12-08 | 2014-01-08 | 花王株式会社 | Emulsified cosmetics |
JP2009242269A (en) * | 2008-03-31 | 2009-10-22 | Kose Corp | Oil-in-water type emulsion cosmetic |
JP2011195460A (en) * | 2010-03-17 | 2011-10-06 | Shiseido Co Ltd | External preparation for skin |
JP2012051872A (en) * | 2010-08-05 | 2012-03-15 | Shiseido Co Ltd | Skin cosmetic |
JP5758670B2 (en) * | 2011-03-29 | 2015-08-05 | 株式会社コーセー | Oil-in-water emulsion composition |
JP6348253B2 (en) * | 2012-01-27 | 2018-06-27 | 株式会社コーセー | Emulsion composition containing stearyl glycyrrhetinate |
JP6010307B2 (en) * | 2012-02-14 | 2016-10-19 | アサヌマ コーポレーション株式会社 | Aqueous cosmetics |
JP6010317B2 (en) * | 2012-03-30 | 2016-10-19 | 株式会社コーセー | Oil-in-water emulsion composition containing an ascorbic acid derivative |
JP2014080397A (en) * | 2012-10-17 | 2014-05-08 | Rocket Soap Co Ltd | Oil-in-water type skin care preparation |
WO2014087990A1 (en) * | 2012-12-04 | 2014-06-12 | ロート製薬株式会社 | Composition for external application |
-
2014
- 2014-10-31 JP JP2014223690A patent/JP6364322B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016088874A (en) | 2016-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6364322B2 (en) | Cosmetic or skin preparation | |
JP6010418B2 (en) | Emulsified composition | |
JP7058943B2 (en) | Oil-in-water emulsification composition | |
JP7384518B2 (en) | Composition for stabilizing poorly soluble ingredients and cosmetic compositions containing the same | |
JP6339376B2 (en) | Cosmetics | |
JP2010184908A (en) | Emulsified composition and cosmetic comprising the same, and skin care preparation for external use | |
JP5662794B2 (en) | Water-in-oil emulsion composition | |
JP6348253B2 (en) | Emulsion composition containing stearyl glycyrrhetinate | |
JP6423701B2 (en) | Cosmetics | |
JP2013063959A (en) | W/o type emulsified hair cosmetic | |
JP7148252B2 (en) | External skin preparations or cosmetics | |
JP5869296B2 (en) | Water-in-oil emulsion composition | |
JP4524098B2 (en) | Emulsifier composition for oil-in-water type, and cosmetics containing the composition | |
JP6747763B2 (en) | Emulsified cosmetics | |
JP6336313B2 (en) | Oil-in-water emulsion composition | |
JP6984394B2 (en) | Underwater oil type emulsified cosmetic | |
JP6918548B2 (en) | Topical skin or cosmetics | |
JP5706223B2 (en) | W / O / W emulsion composition | |
JP7612387B2 (en) | Oil-in-water emulsion composition containing behendimonium ethyl stearyl phosphate | |
JP6081097B2 (en) | Oil-in-water emulsion composition | |
JP6266877B2 (en) | Emulsion composition containing stearyl glycyrrhetinate | |
JP2020147538A (en) | Milky lotion-like skin cosmetic | |
JP7546113B1 (en) | Oil-in-water emulsion cosmetics | |
JP2014237595A (en) | Emulsified composition | |
JP6792632B2 (en) | Emulsified cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20170525 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170714 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180320 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180316 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180515 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180612 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180702 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6364322 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |